01/06 Revium Rx. Announces CFO Changes, Effective May 27, 2026 CI
15/05 Revium Rx. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
21/04 Revium Rx. Appoints Amir Avraham as Permanent Chief Executive Officer, Effective as of February 1, 2026 CI
21/04 Revium Rx. Appoints Shlomi Schwartzblat as Director and Chairman of the Board, Effective April 14, 2026 CI
01/04 Revium Rx. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
31/03 Revium Rx. Auditor Raises 'Going Concern' Doubt CI
17/01 Revium Rx. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
21/25/21 Revium Rx Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections GL
21/25/21 Revium Recovery Inc. Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections CI
04/25/04 Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
14/25/14 Revium Rx. has filed an IPO in the amount of $5 million. CI
05/25/05 Revium Rx (RVRC) Completes Acquisition of LipoVation Ltd. GL
04/25/04 Revium Recovery Inc. completed the acquisition of LipoVac, Ltd. CI
21/22/21 Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd AQ
20/22/20 Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd. AQ
20/22/20 Revium Recovery Inc. entered into a letter of intent to acquire LipoVac, Ltd. CI
07/21/07 Revium Recovery Inc. will Change its Ticker to RVRC from OCBG.D CI
18/20/18 Correction: REVIUM RECOVERY ACQUIRES ANTI-ADDICTION REHABILITATION BUSINESS GL
09/20/09 OC Beverages, Inc. has Changed its Name to Revium Recovery Inc CI
09/20/09 Revium Recovery Inc. has Changed its Ticker to OCBG.D from OCBG CI
No results match your criteria
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!